Table 3. Serious adverse events in ESG in 1,607 cases (59).
Adverse event | Events (%) |
---|---|
Intraabdominal collection | 7 (0.4) |
Hemorrhage requiring intervention | 6 (0.4) |
Refractory symptoms requiring reversal | 3 (0.2) |
Pneumoperitoneum/pneumothorax | 1 (0.1) |
Pulmonary embolism | 1 (0.1) |
Perforation or death | 0 |
ESG, endoscopic sleeve gastroplasty.